SYKNYSE

Stryker Corporation

Healthcare•Medical Devices•United States•56 000 zaměstnanců

273,40 US$

-1,69 US$ (-0,61 %)

Tažením v grafu vyberte úsek a zobrazí se procentuální změna.Tažením dvěma prsty vyberte úsek a zobrazí se procentuální změna.

Kapitálová struktura

Tržní kapitalizace: 104,87 mld. US$
Enterprise Value: 117,49 mld. US$
Hotovost: 3,48 mld. US$
Celkový dluh: 15,45 mld. US$
Čistý dluh: 11,97 mld. US$

Valuace (TTM)

P/E: 28,24×
P/E (fwd): 16,35×
P/FCF: 22,30×
FCF výnos: 4,48 %
EV/EBITDA: 15,93×
P/S: —
P/B: 4,37×
Beta: 0,77

Marže (TTM)

Hrubá marže: 65,59 %
EBITDA marže: 28,55 %
Provozní marže: 27,02 %
Čistá marže: 14,43 %
FCF marže: 18,20 %

Ziskovost a růst

ROE (rentabilita kapitálu): 16,51 %
Růst tržeb (YoY): 9,40 %
Růst zisku (YoY): 44,10 %

Dividenda

Dividendový výnos: 1,28 %
Roční dividenda: 3,52 US$
Výplatní poměr: 36,06 %
Datum ex-dividendy: 2026-09-30

52týdenní rozpětí

267,00 US$392,55 US$

Aktuální: 273,40 US$
Pozice v pásmu: 5 %
Nad ročním minimem: +2,40 %
Pod ročním maximem: -30,35 %

Cena v kontextu

-32,25 %od historického maxima

Historické maximum: 403,53 US$
Datum maxima: 25. 7. 2025
Zpět na maximum: +47,60 %
200denní průměr: 333,47 US$
Odchylka od průměru: -18,01 %

O společnosti

Web

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Vedení společnosti

Mr. Kevin A. Lobo

Generální ředitel (CEO)

Mr. Spencer S. StilesPresident & COO
Mr. Preston W. WellsVP & CFO
Mr. Viju S. MenonGroup President of Global Quality & Operations
Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology
Ms. Emily BaculikVP, Chief Accounting Officer & Corporate Controller
Mr. Robert C. CohenCTO and VP of Global R&D - Joint Replacement
Ms. Debra S. KingVP and Chief Digital & Information Officer
Mr. Nick MeadVice President of Investor Relations
Mr. Robert S. FletcherVP & Chief Legal Officer